泰国急性类鼻疽成人中 Burkholderia pseudomallei 特异性 IgG2 的作用
本研究在泰国急性类鼻疽成人中,用 ELISA 和抗体依赖细胞吞噬试验识别保护性抗体特征。多因素 logistic 回归校正年龄、糖尿病、肾病和中性粒细胞计数后发现,高滴度 Burkholderia pseudomallei 特异性 IgG2 与免于死亡相关。幸存者血清可增强表达中间亲和力 IgG2 受体 FcγRIIa-H/R131 的人单核细胞对细菌的摄取,而低亲和力 FcγRIIa-R131 等位基因单核细胞未见此增强。
要点
- 高滴度 Burkholderia pseudomallei 特异性 IgG2 与急性类鼻疽成人免于死亡相关。
- 幸存者血清增强表达 FcγRIIa-H/R131 的单核细胞摄取细菌。
- 该增强在低亲和力 FcγRIIa-R131 等位基因单核细胞中未观察到。
核心结论
- IgG2 在人类类鼻疽免于死亡中具有重要作用,对基于抗体的治疗和疫苗开发是关键发现。
研究设计与样本
- 研究在泰国急性类鼻疽成人中开展,采用 ELISA 和抗体依赖细胞吞噬试验识别保护性抗体特征,多因素 logistic 回归校正年龄、糖尿病、肾病和中性粒细胞计数。
主要发现
- 高滴度 Burkholderia pseudomallei 特异性 IgG2 与免于死亡相关。
- 幸存者血清较非幸存者血清增强细菌被表达 FcγRIIa-H/R131 的人单核细胞摄取。
- 使用携带低 IgG2 亲和力 FcγRIIa-R131 等位基因的单核细胞时未发现该增强。
临床怎么用
- IgG2 及 FcγRIIa-H/R131 可作为类鼻疽抗体治疗和疫苗开发的潜在免疫靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Melioidosis is a life-threatening infectious disease caused by the gram-negative bacillus Burkholderia pseudomallei. An effective vaccine is needed, but data on protective immune responses in human melioidosis are lacking. We used ELISA and an antibody-dependent cellular phagocytosis assay to identify the major features of protective antibodies in patients with acute melioidosis in Thailand. We found that high levels of B. pseudomallei-specific IgG2 are associated with protection against death in a multivariable logistic regression analysis adjusting for age, diabetes, renal disease, and neutrophil count. Serum from melioidosis survivors enhanced bacteria uptake into human monocytes expressing FcγRIIa-H/R131, an intermediate-affinity IgG2-receptor, compared with serum from nonsurvivors. We did not find this enhancement when using monocytes carrying the low IgG2-affinity FcγRIIa-R131 allele. The findings indicate the importance of IgG2 in protection against death in human melioidosis, a crucial finding for antibody-based therapeutics and vaccine development.
引用
- Chaichana P, Jenjaroen K, Chumseng S, et al. Role of Burkholderia pseudomallei-Specific IgG2 in Adults with Acute Melioidosis, Thailand. Emerg Infect Dis. 2021. PMID: 33496230. doi:10.3201/eid2702.200213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。